Geron (GERN) Net Margin (QoQ) (2010 - 2026)
Geron (GERN) Net Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Geron | 1.04 Mn | -299.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,212.00 |
| Mar 31, 2026 | -2,869.00 |
| Dec 31, 2025 | 6,049.00 |
| Sep 30, 2025 | -541.00 |
| Jun 30, 2025 | 1,661.00 |
| Mar 31, 2025 | -13,136.00 |
| Dec 31, 2024 | 17,481.00 |
| Sep 30, 2024 | 753,933.00 |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | -4.19 Mn |
| Dec 31, 2023 | 5.10 Mn |
| Sep 30, 2023 | 14.24 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | -14.19 Mn |
| Dec 31, 2022 | -2.60 Mn |
| Sep 30, 2022 | 2.63 Mn |
| Jun 30, 2022 | -1.51 Mn |
| Mar 31, 2022 | -2.20 Mn |
| Dec 31, 2021 | 2.14 Mn |
| Sep 30, 2021 | 407,424.00 |